3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Endothelial Cullin3 Mutation Impairs Nitric Oxide-Mediated Vasodilation and Promotes Salt-Induced Hypertension

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Human hypertension caused by in-frame deletion of CULLIN3 exon-9 (Cul3∆9) is driven by renal and vascular mechanisms. We bred conditionally activatable Cul3∆9 transgenic mice with tamoxifen-inducible Tie2-CRE ERT2 mice to test the importance of endothelial Cul3. The resultant mice (E-Cul3∆9) trended towards elevated nighttime blood pressure (BP) correlated with increased nighttime activity, but displayed no difference in daytime BP or activity. Male and female E-Cul3∆9 mice together exhibited a decline in endothelial-dependent relaxation in carotid artery. Male but not female E-Cul3∆9 mice displayed severe endothelial dysfunction in cerebral basilar artery. There was no impairment in mesenteric artery and no difference in smooth muscle function, suggesting the effects of Cul3∆9 are arterial bed-specific and sex-dependent. Expression of Cul3∆9 in primary mouse aortic endothelial cells decreased endogenous Cul3 protein, phosphorylated (S1177) endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) production. Protein phosphatase (PP) 2A, a known Cul3 substrate, dephosphorylates eNOS. Cul3∆9-induced impairment of eNOS activity was rescued by a selective PP2A inhibitor okadaic acid, but not by a PP1 inhibitor tautomycetin. Because NO deficiency contributes to salt-induced hypertension, we tested the salt-sensitivity of E-Cul3∆9 mice. While both male and female E-Cul3∆9 mice developed salt-induced hypertension and renal injury, the pressor effect of salt was greater in female mutants. The increased salt-sensitivity in female E-Cul3∆9 mice was associated with decreased renovascular relaxation and impaired natriuresis in response to a sodium load. Thus, CUL3 mutations in the endothelium may contribute to human hypertension in part through decreased endothelial NO bioavailability, renovascular dysfunction, and increased salt-sensitivity of BP.

          Graphical Abstract

          Graphical Abstract

          Assessment of fraction new over time reveals insight into proteostatic maintenance in muscle collagen.

          Related collections

          Most cited references73

          • Record: found
          • Abstract: not found
          • Article: not found

          Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2.

              Transcription factor Nrf2 is a major regulator of genes encoding phase 2 detoxifying enzymes and antioxidant stress proteins in response to electrophilic agents and oxidative stress. In the absence of such stimuli, Nrf2 is inactive owing to its cytoplasmic retention by Keap1 and rapid degradation through the proteasome system. We examined the contribution of Keap1 to the rapid turnover of Nrf2 (half-life of less than 20 min) and found that a direct association between Keap1 and Nrf2 is required for Nrf2 degradation. In a series of domain function analyses of Keap1, we found that both the BTB and intervening-region (IVR) domains are crucial for Nrf2 degradation, implying that these two domains act to recruit ubiquitin-proteasome factors. Indeed, Cullin 3 (Cul3), a subunit of the E3 ligase complex, was found to interact specifically with Keap1 in vivo. Keap1 associates with the N-terminal region of Cul3 through the IVR domain and promotes the ubiquitination of Nrf2 in cooperation with the Cul3-Roc1 complex. These results thus provide solid evidence that Keap1 functions as an adaptor of Cul3-based E3 ligase. To our knowledge, Nrf2 and Keap1 are the first reported mammalian substrate and adaptor, respectively, of the Cul3-based E3 ligase system.
                Bookmark

                Author and article information

                Contributors
                Journal
                Function (Oxf)
                Function (Oxf)
                function
                Function
                Oxford University Press
                2633-8823
                2022
                08 April 2022
                08 April 2022
                : 3
                : 3
                : zqac017
                Affiliations
                Deparment of Physiology, Cardiovascular Center, Medical College of Wisconsin , Milwaukee, 53226 Wisconsin, USA
                Deparment of Physiology, Cardiovascular Center, Medical College of Wisconsin , Milwaukee, 53226 Wisconsin, USA
                Department of Neuroscience and Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa , Iowa City, 52242 Iowa, USA
                Deparment of Physiology, Cardiovascular Center, Medical College of Wisconsin , Milwaukee, 53226 Wisconsin, USA
                Deparment of Physiology, Cardiovascular Center, Medical College of Wisconsin , Milwaukee, 53226 Wisconsin, USA
                Deparment of Physiology, Cardiovascular Center, Medical College of Wisconsin , Milwaukee, 53226 Wisconsin, USA
                Deparment of Physiology, Cardiovascular Center, Medical College of Wisconsin , Milwaukee, 53226 Wisconsin, USA
                Department of Neuroscience and Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa , Iowa City, 52242 Iowa, USA
                Department of Neuroscience and Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa , Iowa City, 52242 Iowa, USA
                Department of Neuroscience and Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa , Iowa City, 52242 Iowa, USA
                Deparment of Physiology, Cardiovascular Center, Medical College of Wisconsin , Milwaukee, 53226 Wisconsin, USA
                Department of Neuroscience and Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa , Iowa City, 52242 Iowa, USA
                Deparment of Physiology, Cardiovascular Center, Medical College of Wisconsin , Milwaukee, 53226 Wisconsin, USA
                Deparment of Physiology, Cardiovascular Center, Medical College of Wisconsin , Milwaukee, 53226 Wisconsin, USA
                Author notes
                Address correspondence to C.D.S. (e-mail: csigmund@ 123456mcw.edu )
                Author information
                https://orcid.org/0000-0003-2013-2863
                https://orcid.org/0000-0001-9737-0873
                https://orcid.org/0000-0002-1453-0921
                Article
                zqac017
                10.1093/function/zqac017
                9045850
                35493997
                c8e58a31-ecc6-4d9c-95cf-6bd39c173ec4
                © The Author(s) 2022. Published by Oxford University Press on behalf of American Physiological Society.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@ 123456oup.com

                History
                : 27 January 2022
                : 29 March 2022
                : 30 March 2022
                Page count
                Pages: 18
                Funding
                Funded by: National Institutes of Health, DOI 10.13039/100000002;
                Award ID: HL084207
                Award ID: HL144807
                Award ID: HL134850
                Award ID: 18EIA33890055
                Funded by: American Heart Association, DOI 10.13039/100000968;
                Award ID: 15SFRN23480000
                Categories
                Research Article
                AcademicSubjects/SCI00960
                AcademicSubjects/MED00772
                AcademicSubjects/SCI01360
                AcademicSubjects/SCI01270

                endothelium,vasodilation,nitric oxide,hypertension,salt sensitivity

                Comments

                Comment on this article